Trial watch: Dendritic cell-based anticancer therapy

The use of patient-derived dendritic cells (DCs) as a means to elicit therapeutically relevant immune responses in cancer patients has been extensively investigated throughout the past decade. In this context, DCs are generally expanded, exposed to autologous tumor cell lysates or loaded with specif...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Bloy, Norma, Pol, Jonathan, Aranda, Fernando, Eggermont, Alexander, Cremer, Isabelle, Fridman, Wolf Hervé, Fučíková, Jitka, Galon, Jérôme, Tartour, Eric, Spisek, Radek, Dhodapkar, Madhav V., Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2014
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292311/
https://ncbi.nlm.nih.gov/pubmed/25941593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.963424
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados